INTRODUCTION
nucleosides have been reported (Poulsen et al., 1998) . 8-Hydroxy-2'-deoxyguanosine (8-OHdG) is one of the oxidative DNA modifications and is extensively used for study of mutagenicity (Cheng et al., 1992) .
Metallothionein (MT) is a cysteine-rich low-molecuzinc, copper, cadmium and mercury (Miles et al., 2000) . There are four isoforms of MT, namely MT-I, MT-II, MT-III and MT-IV. MT-I and MT-II are expressed in all tissues (Miles et al., 2000) . MT-III is expressed mainly in the brain and MT-IV in squamous epithelia. MT has been known to be involved in many physiological and pathophysiological processes such as intracellular storage, transport and metabolism of heavy metals, regulating essential trace metal homeostasis and playing a protective role in heavy metal toxicity (Miles et al., 2000) . MT also plays a protective role against toxicity of free radical-inducing agents such as paraquat, adriamycin and ionizing radiation (Satoh et al., 1988 (Satoh et al., , 1992 Sato and Bremner, 1993; Cai et al., 1999) . Detailed examinations of MT with free radicals have been extensively undertaken and have demonstrated that MT is a potent antioxidant to prevent various oxidative injuries from reactive oxygen and nitrogen species in vitro and in vivo (Sato and Bremner, 1993; Cai et al., 1999 Cai et al., , 2000 . In addition, MT can reduce the adverse effects of the chemotherapeutic agents adriamycin and cis-diamminedichloroplatinum (II) (cisplatin) and other alkylating agents. (Satoh et al., 1988; Naganuma et al., 1987; Nakagawa et al., 1995) . Pretreatment with MT-inducing metals such as zinc and bismuth can suppress chemical carcinogenesis caused by 7,12-dimethylbenz [a] anthracene (DMBA), 3-methyl cholanthrene, cisplatin and melphalan (Poswillo and Cohen, 1971; Duncan and Dreosti, 1975; Satoh et al., 1993; Cherian et al., 1994) . Also the incidence of Xray-induced thymic lymphomas was lowered by administration of bismuth nitrate as an MT inducer (Cai et al., 1999) . Recently, Cherian et al. (2003) have reported that high expression of MT in certain tumors may block apoptosis and may be related to tumor progression; a central role for p53 is to act as a tumor suppressor by inducing apoptosis.
Recently, MT-I/II null mice with both MT-I and MT-II null mutations have been developed and widely used in toxicological experiments (Michalska and Choo, 1993) . Some researchers have reported that MT-I/II null mice were more susceptible than wild-type mice in chemicaland metal-induced carcinogenesis (Zhang et al., 1998; Kondo et al., 1999; Suzuki et al., 2003; Waalkes et al., 2004) .
However, the involvement of MT in the genotoxicity of B [a] P is not clear. MT-I/II null mice have been proven to be a good tool for elucidation of the normal functhe present study, to elucidate the genotoxicity of B [a] P and the ability of MT to modify B [a] P toxicity, we investigated the susceptibility of MT-I/II null mice to B [a] Pinduced DNA damage such as chromosomal aberrations, DNA strand breaks and oxidative DNA damage. (Michalska and Choo, 1993) . F1 hybrid mice were mated with C57BL/6 mice and their offspring were backcrossed to C57BL/6 for six generations. Both MT-I/II null mice and wild-type mice were generated by matings of heterozygous mice.
MATERIALS AND METHODS

Chemicals
MT-I/II null mice and wild-type mice were routinely bred in the vivarium of the Gifu Pharmaceutical University. Both strains of mice were housed in cages in ventilated animal rooms with a controlled temperature of 24 ± 2°C, a relative humidity of 55 ± 10% and a 12 hr light/ dark cycle. The mice were maintained on standard laboratory chow and tap water ad libitum, and they received humane care throughout the experiment according to the guidelines of the Gifu Pharmaceutical University.
Treatments
Ten-week-old male MT-I/II null mice and wild-type mice were randomized into control and experimental groups (the groups of 0, 12, 24 and 48 hr after B [a] P administration on MT-I/II null mice consisted of 4 mice and the other group consisted of 5 mice). The groups of mice were given a single oral administration of B [a] P at a dose of 250 mg/kg. Peripheral blood was collected from the mouse tail vein, and then the liver and bone marrow were removed from each mouse under diethyl ether anesthesia at 0, 6, 12, 24 and 48 hr after the injection.
Another group of mice were orally administered a single dose of B [a] P at a dose of 30 to 750 mg/kg. Peripheral blood was collected from the mouse tail vein under diethyl ether anesthesia at 48 hr after injection.
Micronucleus test
The peripheral blood smeared on a slideglass (Matsunami Glass Industries, Osaka, Japan) was stained with acridine orange according to the method described by Hayashi et al. (1990) . For each animal, 1,000 reticulocytes (RET) were scored for the micronucleus (MN) and the frequencies of micronucleated reticulocytes (MNRET) were expressed as percent of RET.
Single cell gel electrophoresis (comet) assay
The liver was gently homogenized according to the method described by Sasaki et al. (1997) with some moddone according to the method described by Singh et al. quantify the average DNA strand breaks, all of them were (normal; score = 0); tail length < head length (score = 1); tail length < 2 × head length (score = 2); tail length < 3 × head length (score = 3). Comet scores were the calculated sum of 50 nuclei.
Determination of 8-OHdG in DNA
The DNA was extracted from the liver with the DNA Extractor WB Kit according to the method of Kasai et al. (1987) . DNA concentration was determined by the absorbance at 260 nm (A 260 1.0 = 50 μg DNA). The absorbance ratio (A 260 /A 280 ) was between 1.80 and 1.85. The extracted DNA was digested with 6 units of nuclease P 1 and 200 mM sodium acetate (pH 4.8) at 37°C for 1 hr. The samples were incubated at 37°C for 1 hr after 2 units of alkaline phosphatase and 1 M Tris-HCl (pH 7.4) were added.
The amounts of 8-OHdG in the liver were measured by an ELISA kit according to the manufacturer's instructions. 8-OHdG amounts were presented as the 8-OHdG μg/g DNA ratio.
Immunohistochemical detection of 8-OHdG
The liver was fixed in 10% neutral buffered forma--sue 5-μm sections were prepared and placed on a slide glass (Matsunami Glass Industries, Osaka, Japan) and with 3% hydrogen peroxide for 15 min and washed with 0.01 M PBS. Mouse anti 8-OHdG antibody (1:400) was applied to each section at 4°C overnight.
Hepatic CYP1A enzymatic activity 7-Ethoxyresorufin-O-deethylation (EROD) activity in liver microsomes was determined by the method of Shimada et al. (1998) . The EROD activity was expressed proteins.
MT concentration measurement
MT (MT-I and MT-II isoforms) concentrations in the liver were measured by radioimmunoassay (Tohyama et al. (1990) using sheep anti-rat MT-I antiserum. Ten % liver homogenate was prepared in 10 mM Tris-HCl.
Statistical analysis
All values are expressed as the mean ± S.D.. Differences in the mean values were assessed by the ANOVA test followed by Newman-Keuls tests for post hoc com--cant at p < 0.05.
RESULTS
MN test
The results of the MN test, which is an indicator of chromosomal aberration, are shown in Fig. 1 . The fre-MT-I/II null mice at 48 hr after the B[a]P (250 mg/kg) administration (Fig. 1A) . However, the frequencies of MNRET in wild-type mice were not increased by the B[a]P treatment. 
Comet assay
Comet scores, an indicator of DNA strand breaks, in hr after B [a] P administration (Fig. 2) . In contrast, comet scores in the wild-type mice were not increased by B[a]P treatment.
Determination of 8-OHdG
The 8-OHdG levels, an indicator of oxidative DNA - cantly increased compared with those in wild-type mice at 6 and 12 hr after B [a] P administration (Fig. 3) . At 6 and 12 hr after B[a]P administration, 8-OHdG levels in the livers of MT-I/II null mice were 4-fold and 2.5-fold higher than those in wild-type mice, respectively. The 8-OHdG immunoreactivity in the livers of MT- I/II null mice and wild-type mice treated with B [a] P is shown in Fig. 4 . Little 8-OHdG was detected in the livers of untreated wild-type mice and MT-I/II null mice (Figs. 4A and F) . In wild-type mice, 8-OHdG in the liver was slightly increased only at 12 hr after B[a]P administration (Fig. 4C) . In contrast, 8-OHdG in the livers of MT-I/II null mice was apparently increased at 6 and 12 hr after administration (Figs. 4G and H) . (Fig. 5) . However, the hepatic EROD activities of B [a] P-administered mice were not changed between the MT-I/II null mice and wild-type mice.
MT concentration in the liver
MT concentrations were determined in the livers of wild-type mice and MT-I/II null mice treated with B [a] P. The hepatic MT levels in the wild-type mice were significantly increased by B [a] P treatment. However, MT was not detected in the livers of MT-I/II null mice with or without B [a] P treatment (Table 1) .
DISCUSSION
Because B [a] P is known to induce chromosomal aberration, many investigators have used the MN test for detecting B [a] P mutagenicity in vivo (Shimada et al., 1992) . In the present study, MT-I/II null mice are more susceptible to chromosomal aberration than wild-type mice at various doses of B [a] P. Itoh and Shimada (1996) have reported that pretreatment with an MT inducer suppressed the MN induction by chromium compounds and selenium compounds. MN induced by anticancer drugs such as cisplatin, adriamycin, cyclophosphamide and Lphenylalanine mustard was also prevented by pretreatment with MT inducers (Nakagawa et al., 1995) . These results suggest that MT may play a protective role against chromosomal aberration induced by several compounds including B [a] P. Comet assay is a very sensitive technique for detecting individual eukaryote cells of multiple classes of DNA damage and incomplete excision repair sites associated with the elimination of DNA damage (Fairbairn et al., 1995) . Sasaki et al. (1997) used the comet assay to detect DNA damage by various mutagens and found that hepatic DNA strand breaks were increased by oral administration of B [a] P. In DNA strand breaks caused by dimethylarsinic acid, MT-I/II null mice were more susceptible than wild-type mice (Jia et al., 2004) . The hepatic comet scores of MT-I/II null mice treated with B[a]P have a greater tendency to high score than wild-type mice in the present study.
The major metabolic active pathway of B[a]P proceeds through trans-dihydrodiol to anti-diol epoxide which alkylates the N 2 group of guanosine, and BPDE-N 2 -dG, which is the major adduct formed, is associated with B[a]P carcinogenesis (Culp and Beland, 1994) . In addition, during metabolic processes, B [a] P also produces various quinone derivatives and ROS which are mutagens and carcinogens (Penning et al., 1996) . Formation of 8-OHdG has been widely used as a biomarker of oxidative DNA damage (Kasai et al., 1987) . 8-OHdG is thought to be a promutagenic lesion because this lesion induces G:C to T:A transversion unless repaired prior to replication (Cheng et al., 1992) . It has been suggested -mation of 8-OHdG in the target organs of animals treated with free radical generating carcinogens (Cho et al., 1993) . Oral administration of B [a] P to Sprague-Dawley rats increased hepatic 8-OHdG and decreased catalase and superoxide dismutase activities. (Kim and Lee, 1997) . Our results showed that susceptibility to oxidative DNA damage induced by B[a]P was extremely increased in MT-I/II null mice.
In the present study we found that MT plays an important role in defense against B [a] P-caused genotoxicity such as chromosomal aberration, DNA strand breaks and oxidative DNA damage. By considering the peak times of B [a] P-induced DNA damage in three genotoxicity assays, the oxidative DNA damage occurred at first, then the In addition, at the highest dose (750 mg/kg) of B [a] P, two a]P administration. Park et al. (2001) have reported that MT-I/II null mice were susceptible to cadmium and other metal-mediated lethalities. Thus, MT may protect against the lethality of B [a] (Conney, 1982) . B [a] P is also known to induce CYP1A1, CYP1A2 and CYP1B1 through an arylhydrocarbon receptor-dependent mechanism (Shimada et al., 2002 On the other hand, the synthesis of MT is induced by many metals, hormones, cytokines, stresses and chemicals (Miles et al., 2000; Sato and Bremner, 1993; Cai et al. B[a] P can induce MT in the liver. The hepatic MT levels in the wild-type mice were elevated at 6 hr and maintained until 24 hr after B [a] P administration. Therefore, B [a] P-caused genotoxicity such as oxidative DNA damage and DNA strand breaks in the liver may be prevented by not only endogenous MT but also B[a]P-induced MT.
Recently, MT-I/II null mice have been used to study the role of MT in the carcinogenesis of various mutagens. Zhang et al. (1998) have found that MT-I/II null mice were very sensitive to skin carcinogenesis caused by a single topical application of DMBA. Suzuki et al. (2003) have also demonstrated that MT-I/II null mice were sensitive to DMBA/12-O-tetradecanoylphorbol-13-acetateinduced two-stage skin carcinogenesis. In addition, Kondo et al. (1999) have reported that MT-I/II null mice had a high incidence of urinary bladder tumors induced by Nbutyl-N-(4-hydroxybutyl)nitrosamine. These reports suggest that MT-I/II null mice are extraordinarily susceptible to chemical carcinogens. B [a] P can induce various tumors such as mammary, uterine, lung, skin, liver, stomach, esophagus and leukemia depending on routes of administration and animal species (IARC monographs, in preparation). The present study revealed that MT-I/II null mice have an increased susceptibility to DNA dam-age caused by B [a] P oral administration. MT may prevent B [a] P-induced carcinogenesis because MT prevents B [a] P-induced DNA damage.
The mechanism of the protective role of MT in B [a] Pinduced DNA damage is unknown. However, its mechanism is related to DNA adduct formation and oxidative DNA damage. MT is a potent antioxidant to various oxidative injuries from ROS in vivo (Satoh et al., 1988 (Satoh et al., , 1992 Sato and Bremner, 1993; Cai et al., 1999) . Thus, it is thought that prevention of B [a] P-induced DNA damage by MT may be due to scavenging of the ROS generated by B [a] P.
